Clinical Trial Update: High Density Lipoprotein (HDL) Functionality in Metabolic Syndrome

View source ↗

Summary

This clinical trial update concerns HDL functionality in individuals with metabolic syndrome (metabolic syndrome X). The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Snippet

Sponsor: The University of Western Australia | Conditions: Metabolic Syndrome X | Status: UNKNOWN